ESALF
Price
$34.83
Change
-$0.05 (-0.14%)
Updated
Sep 25 closing price
Capitalization
9.85B
HKMPF
Price
$21.87
Change
-$0.22 (-1.00%)
Updated
Sep 24 closing price
Capitalization
4.83B
Interact to see
Advertisement

ESALF vs HKMPF

Header iconESALF vs HKMPF Comparison
Open Charts ESALF vs HKMPFBanner chart's image
Eisai
Price$34.83
Change-$0.05 (-0.14%)
Volume$700
Capitalization9.85B
Hikma Pharmaceuticals
Price$21.87
Change-$0.22 (-1.00%)
Volume$985
Capitalization4.83B
ESALF vs HKMPF Comparison Chart in %
Loading...
ESALF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HKMPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ESALF vs. HKMPF commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESALF is a Buy and HKMPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (ESALF: $34.83 vs. HKMPF: $21.87)
Brand notoriety: ESALF and HKMPF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ESALF: 68% vs. HKMPF: 62%
Market capitalization -- ESALF: $9.85B vs. HKMPF: $4.83B
ESALF [@Pharmaceuticals: Generic] is valued at $9.85B. HKMPF’s [@Pharmaceuticals: Generic] market capitalization is $4.83B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESALF’s FA Score shows that 2 FA rating(s) are green whileHKMPF’s FA Score has 1 green FA rating(s).

  • ESALF’s FA Score: 2 green, 3 red.
  • HKMPF’s FA Score: 1 green, 4 red.
According to our system of comparison, ESALF is a better buy in the long-term than HKMPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESALF’s TA Score shows that 5 TA indicator(s) are bullish while HKMPF’s TA Score has 3 bullish TA indicator(s).

  • ESALF’s TA Score: 5 bullish, 3 bearish.
  • HKMPF’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ESALF is a better buy in the short-term than HKMPF.

Price Growth

ESALF (@Pharmaceuticals: Generic) experienced а +6.53% price change this week, while HKMPF (@Pharmaceuticals: Generic) price change was -2.24% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.88%. For the same industry, the average monthly price growth was +23.85%, and the average quarterly price growth was +67.10%.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.88% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESALF($9.85B) has a higher market cap than HKMPF($4.83B). ESALF has higher P/E ratio than HKMPF: ESALF (31.40) vs HKMPF (13.10). ESALF YTD gains are higher at: 35.559 vs. HKMPF (-6.227). ESALF has higher annual earnings (EBITDA): 104B vs. HKMPF (734M). ESALF has more cash in the bank: 266B vs. HKMPF (236M). HKMPF has less debt than ESALF: HKMPF (1.56B) vs ESALF (188B). ESALF has higher revenues than HKMPF: ESALF (789B) vs HKMPF (3.22B).
ESALFHKMPFESALF / HKMPF
Capitalization9.85B4.83B204%
EBITDA104B734M14,169%
Gain YTD35.559-6.227-571%
P/E Ratio31.4013.10240%
Revenue789B3.22B24,534%
Total Cash266B236M112,712%
Total Debt188B1.56B12,067%
FUNDAMENTALS RATINGS
ESALF vs HKMPF: Fundamental Ratings
ESALF
HKMPF
OUTLOOK RATING
1..100
2786
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
8
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
679
PRICE GROWTH RATING
1..100
4785
P/E GROWTH RATING
1..100
8596
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HKMPF's Valuation (8) in the null industry is in the same range as ESALF (13). This means that HKMPF’s stock grew similarly to ESALF’s over the last 12 months.

HKMPF's Profit vs Risk Rating (100) in the null industry is in the same range as ESALF (100). This means that HKMPF’s stock grew similarly to ESALF’s over the last 12 months.

ESALF's SMR Rating (6) in the null industry is significantly better than the same rating for HKMPF (79). This means that ESALF’s stock grew significantly faster than HKMPF’s over the last 12 months.

ESALF's Price Growth Rating (47) in the null industry is somewhat better than the same rating for HKMPF (85). This means that ESALF’s stock grew somewhat faster than HKMPF’s over the last 12 months.

ESALF's P/E Growth Rating (85) in the null industry is in the same range as HKMPF (96). This means that ESALF’s stock grew similarly to HKMPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ESALFHKMPF
RSI
ODDS (%)
Bearish Trend 1 day ago
40%
Bullish Trend 1 day ago
33%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
57%
Bullish Trend 1 day ago
40%
Momentum
ODDS (%)
Bullish Trend 1 day ago
43%
Bearish Trend 1 day ago
33%
MACD
ODDS (%)
Bullish Trend 1 day ago
37%
Bearish Trend 1 day ago
32%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
39%
Bearish Trend 1 day ago
32%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
47%
Bearish Trend 1 day ago
41%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
11%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
55%
Bullish Trend 1 day ago
35%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
43%
View a ticker or compare two or three
Interact to see
Advertisement
ESALF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HKMPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TAREX26.40N/A
N/A
Third Avenue Real Estate Value Instl
HHCZX17.05N/A
N/A
NexPoint Event Driven Z
GCMAX38.30N/A
N/A
Goldman Sachs Mid Cap Value A
FRVFX47.46N/A
N/A
Franklin Small Cap Value C
RIDFX27.29-0.11
-0.40%
American Funds Income Fund of Amer R5

ESALF and

Correlation & Price change

A.I.dvisor tells us that ESALF and ESAIY have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESALF and ESAIY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESALF
1D Price
Change %
ESALF100%
-0.16%
ESAIY - ESALF
26%
Poorly correlated
-2.50%
DVAX - ESALF
23%
Poorly correlated
-2.31%
KHTRF - ESALF
22%
Poorly correlated
N/A
SHPH - ESALF
22%
Poorly correlated
-6.22%
BLMH - ESALF
21%
Poorly correlated
N/A
More

HKMPF and

Correlation & Price change

A.I.dvisor tells us that HKMPF and AMPH have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HKMPF and AMPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HKMPF
1D Price
Change %
HKMPF100%
N/A
AMPH - HKMPF
24%
Poorly correlated
-1.90%
CAIHF - HKMPF
24%
Poorly correlated
N/A
HLTRF - HKMPF
11%
Poorly correlated
N/A
GRUSF - HKMPF
9%
Poorly correlated
-4.44%
ESALF - HKMPF
7%
Poorly correlated
-0.16%
More